Company Filing History:
2 out of 5 
1 out of 1 
1 out of 2,946 
Years Active: 1999-2009
Title: **Sylvia Holden: A Pioneer in Immunocytokine Research**
Introduction
Sylvia Holden, an innovative inventor based in Woburn, MA, has significantly contributed to the field of biotechnology with her groundbreaking work in immunocytokine therapies. With a total of four patents to her name, her inventions focus on enhancing immune responses in tumor treatment, showcasing her prowess as a scientist and inventor.
Latest Patents
One of Sylvia’s most recent patents is titled "Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents." This invention discloses methods and compositions designed to treat tumors by enhancing the uptake of immunocytokines into them. The approaches utilized in this patent aim to reduce tumor size and metastasis in mammals, representing a significant advancement in cancer treatment methodologies. Additionally, she has worked on quinone derivatives, further showcasing her diverse expertise in medicinal chemistry.
Career Highlights
Throughout her career, Sylvia has been associated with renowned institutions, notably the Shionogi Bioresearch Corporation and Shionogi Bioresearch Corp. Her role in these organizations has enabled her to work at the forefront of biopharmaceutical innovations, focusing on developing therapies that can enhance immune system efficacy against tumors.
Collaborations
During her tenure at these companies, Sylvia collaborated with esteemed professionals, including Mitsunori Ono and Keizo Koya. These partnerships were instrumental in her research and helped foster a team environment that encouraged innovative solutions to complex medical challenges.
Conclusion
Sylvia Holden continues to be a vital contributor to the field of immunocytokine therapy. With her inventive spirit and dedication to advancing cancer treatment, she exemplifies the role of an accomplished inventor in the modern scientific landscape. Her ongoing work has the potential to impact many lives, emphasizing the importance of innovation in healthcare.